| Forum of Asia Huaxia Pharmacoeconomics and Health Technology Assessment |
 |
| Forum of Asia Huaxia Pharmacoeconomics and Health Technology Assessment |
| Background of health technology assessment (HTA) Prof Lan Chung-Fu |
The HTA process and main concerns from a global perspective |
Experience in setting up PE guideline in Taiwan
|
| Experience in setting up PE guideline in China Prof Hu Shan-Lian |
| How to select the major comparator in a PE study? Prof Li Shu-Chuen |
In what areas government can use PE theory for decision making |
| Factors influencing the transferability of PE data Prof Chen Wen |
| The meaning of cost-effectiveness threshold and its true value Prof Lan Chung-Fu |
| Major factors of concern in budget impact analysis Dr Tony YH Tarn |
| Incentives for the pharmaceutical industry to invest in PE studies Prof Li Shu-Chuen |
| How to deal with priority setting from the industry¡¦s perspective? Mr. Lin Jung-Hung |
| Discrete event simulation in evaluation of pharmacoeconomics Prof. Paul H Luh |
| Organisers | |||
 |
 |
 |
 |
| School of Pharmacy, CUHK | International Society for Pharmacoeconomics and Outcomes Research | Fudan University | Taiwan Society for Pharmacoeconomics and Outcome Research |
